Although several studies demonstrate conflicting roles on exogenous Ang-(1–7) treatment in renal disease progression, previous UUO mouse studies [10, 11] did not detail any effects resulting from alterations in AT1R expression. This evidence concerns the gene AGTR1 and kidney disorder.